Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04672798 · ClinicalTrials.gov registry record · NA
BRITEPath- Phase 2
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT04672798 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 101 participants.
The verdict
NCT04672798, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
BRITEPath (BP) aims to support co-located mental health clinicians in the development of a high quality, effective, and personalized safety plan for referred patients who screen positive for depression and/or suicidal ideation. BRITEPath utilizes BRITE, a safety planning and emotion regulation app that is loaded on the patient's smart phone and has previously been shown to be well accepted and to reduce suicide attempts compared to usual care in psychiatric inpatients (HR = 0.49). To support mental health clinicians in the development of effective safety plans, study investigators will develop Guide2Brite (G2B), which provides step-by-step instructions for the mental health clinician on how to populate BRITE onto the patient's smartphone and BRITEBoard, a clinician dashboard that tracks patient symptoms, app use, and rating on helpfulness of different interventions assessed through BRITE.
Interventions
- BEHAVIORAL Treatment As Usual (TAU)
- BEHAVIORAL BRITEPath
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04672798
The ClinicalTrials.gov registry entry for NCT04672798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment As Usual (TAU) is the first listed.
NCT04672798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04672798 about?
NCT04672798 is a clinical study titled "BRITEPath- Phase 2". BRITEPath (BP) aims to support co-located mental health clinicians in the development of a high quality, effective, and personalized safety plan for referred patients who screen positive for depression and/or suicidal ideation. BRITEPath utilizes BRITE, a safety planning and emotion regulation app ...
What is the current status of trial NCT04672798?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2020-11-05. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT04672798?
The interventions under investigation include: Treatment As Usual (TAU) (BEHAVIORAL), BRITEPath (BEHAVIORAL).
Who is sponsoring clinical trial NCT04672798?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.